1. ALLA AKTIER
  2. NYHETER
  3. FLERIE

Flerie

Nyheter Flerie Nyheter alla bolag

NET ASSET VALUE – 31 March 2025

MARKN.

On the 31 March 2025 Flerie AB's Net Asset Value (NAV) was SEK 3,947 million and NAV per share was SEK 50.56.



Allocation of NAV		Share of portfolio companyFair value (MSEK)Part of NAV per share (SEK)Share of NAV
Product Development    
Prokarium42%4565.8411.6%
Empros Pharma79%2042.625.2%
Xspray Pharma18%1922.464.9%
KAHR Medical31%1892.434.8%
Atrogi37%1762.254.4%
Lipum57%1702.174.3%
Xintela61%1622.084.1%
Microbiotica10%1301.663.3%
Geneos Therapeutics12%961.232.4%
Toleranzia66%791.012.0%
Mendus24%740.941.9%
AnaCardio14%690.891.8%
EpiEndo Pharmaceuticals9%540.691.4%
Synerkine Pharma43%540.691.4%
Vitara Biomedical11%500.641.3%
Buzzard Pharmaceuticals14%290.370.7%
Sixera Pharma24%270.350.7%
Egetis Therapeutics2%230.290.6%
Alder Therapeutics21%170.220.4%
Amarna Therapeutics58%110.140.3%
Strike Pharma16%90.110.2%
Total 2,27029.0857.5%





Commercial Growth    
NorthX Biologics92%1892.424.8%
Symcel31%1742.234.4%
Chromafora31%730.931.8%
Nanologica43%480.611.2%
Frontier Biosolutions2%180.230.5%
Bohus Biotech45%170.210.4%
Provell Pharmaceuticals*72%00.000.0%
Total 5186.6413.1%





Limited Partnerships, total 851.092.2%
     
Assets related to Portfolio companies 2623.356.6%
Other assets and liabilities 81110.3920.6%
     
Net asset value 3,94750.56100.0%
  

 

* indirect shares in Provell Pharmaceuticals

For more information:

Ted Fjällman, CEO
Email: ir@flerie.com

Flerie in brief
Flerie is an active long-term life science investor, with a broad and diversified portfolio of innovative companies based on pioneering science. We invest in product development and commercial growth opportunities globally alongside other leading investors, focusing predominantly on private companies that are otherwise difficult to access. Flerie’s active ownership model, broad network and resources support and accelerate the development of the portfolio projects, creating value for shareholders. Flerie AB’s ordinary share is listed on Nasdaq Stockholm with the ticker FLERIE. For further information please visit www.flerie.com

Attachments
NET ASSET VALUE – 31 March 2025

Datum 2025-04-03, kl 08:00
Källa MFN
Bifogade filer
NET ASSET VALUE – 31 March 2025
Affiliate
Investera som eToros bästa investerare! Med eToros CopyTrader™, kan du automatiskt kopiera andra investerares beslut. Hitta investerare som du tror på och kopiera deras investeringar i realtid. Inga extra avgifter tas ut för funktionen.
Copy Trading innebär inte investeringsrådgivning. Värdet på dina investeringar kan gå upp eller ner. Du riskerar ditt kapital.